None listed
Conditions
Interventions
Four different treatments are to be used in this study. 1)single oral dose of 60 mg of coenzyme Q10 supplement Q-Gel (2 x 30 mg capsules); 2) single oral dose of 150 mg of coenzyme Q10 supplement Q-Gel (5 x 30 mg capsules); 3) single oral dose of 300 mg of coenzyme Q10 supplement Q-Gel (10 x 30 mg capsules); 4) single oral dose of 300 mg of coenzyme Q10 supplement Q-Gel (3 x 100 mg capsules). Each participant will receive all four treatments, one per week for four weeks.
Treatments will be giv
Four different treatments are to be used in this study. 1)single oral dose of 60 mg of coenzyme Q10 supplement Q-Gel (2 x 30 mg capsules); 2) single oral dose of 150 mg of coenzyme Q10 supplement Q-Gel (5 x 30 mg capsules); 3) single oral dose of 300 mg of coenzyme Q10 supplement Q-Gel (10 x 30 mg capsules); 4) single oral dose of 300 mg of coenzyme Q10 supplement Q-Gel (3 x 100 mg capsules). Each participant will receive all four treatments, one per week for four weeks. Treatments will be given between 0800 and 0900 hours, after an overnight fast. For all doses, blood samples will be drawn at time 0, 2, 4, 6, 8, and 10 hours after the dose for the measurement of coenzyme Q10 in plasma. Lipid profiles (total cholesterol, LDL- and HDL-cholesterol and triglycerides) will also be measured on all samples.
Sponsors
Canterbury Health Laboratories
Study design
Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
Male
Age
18 Years to 30 Years
Healthy volunteers
No
Inclusion criteria
Healthy.
Exclusion criteria
Smoker. Taking any supplements or prescription medication on a regular basis. Intercurrent illness.
Outcome results
None listed